SOPHiA DDM™ Dx HRD Solution
Homologous Recombination Deficiency in Cancer
CommercialCE-IVD Marked
Key Facts
Indication
Homologous Recombination Deficiency in Cancer
Phase
Commercial
Status
CE-IVD Marked
Company
About SOPHiA GENETICS
SOPHiA GENETICS is a Swiss health tech company on a mission to democratize data-driven medicine globally through its AI-powered, cloud-native SOPHiA DDM™ platform. The company has achieved significant scale, having analyzed over 2.3 million genomic profiles and serving more than 990 healthcare institutions across 75+ countries. Its strategy centers on expanding its platform's capabilities from genomics into radiomics and multimodal data analysis, while deepening its network effects within the clinical and biopharma ecosystems to drive adoption and insights.
View full company profile